European capital markets require efforts to attract biotech listings
Experts are looking at broader reforms and reorganization to revitalise biotech’s interest in European capital markets.
Experts are looking at broader reforms and reorganization to revitalise biotech’s interest in European capital markets.
Saudi Arabia’s pharmaceutical industry is entering a new phase. While local manufacturing remains central to strengthening pharmaceutical security, the ambition is expanding beyond conventional localisation towards an integrated ecosystem built...
Anthropic plots IPO amid ongoing foray into drug development
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
How DFE Pharma supports confident continuous manufacturing decisions